Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
Felip, E., Shaw, A.T., Bearz, A., Camidge, D.R., Solomon, B.J., Bauman, J.R., Bauer, T.M., Peters, S., Toffalorio, F., Abbattista, A., Thurm, H., Peltz, G., Wiltshire, R., Besse, B.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations
Solomon, B.J., Martini, J.-F., Ou, S.-H.I., Chiari, R., Soo, R.A., Bearz, A., Li, S., Thurm, H., Lin, C.-C., Riely, G.J., Bauer, T.M., Shaw, A.T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Impact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC)
Peters, S., Shaw, A.T., Besse, B., Felip, E., Solomon, B.J., Soo, R.A., Bearz, A., Gadgee, S.M., Lin, C.-C., Kao, S., Seto, T., Masters, E.T., Abbattista, A., Clancy, J.S., Thurm, H., Reisman, A., Camidge, D.R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The Role of BKCa Channels in Electrical Signal Encoding in the Mammalian Auditory Periphery
Oliver, Dominik, Taberner, Annette M, Thurm, Henrike, Sausbier, Matthias, Arntz, Claudia, Ruth, Peter, Fakler, Bernd, Liberman, M. Charles
Published in The Journal of neuroscience (07.06.2006)
Published in The Journal of neuroscience (07.06.2006)
Get full text
Journal Article
MA06.08 Kinetics and Management of Adverse Events Associated with Lorlatinib after 5 Years of Follow-Up in the CROWN Study
Bauer, T., Solomon, B.J., Mazieres, J., Kim, D.-W., Cortinovis, D., Inoue, T., Sharma, R., Thurm, H., Polli, A., Liu, G.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
979P Long-term intracranial safety and efficacy analyses from the phase III CROWN study
Bearz, A., Felip, E., Mazieres, J., de Marinis, F., Bauer, T., Polli, A., Messina, R., Thurm, H., Thomaidou, D., Mok, T.S.K., Solomon, B.J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1199P Dose modification for the management of CNS adverse events in the phase III CROWN study of lorlatinib in non-small cell lung cancer (NSCLC)
Solomon, B.J., Mok, T.S.K., Hayashi, H., Bearz, A., Penkov, K.D., Wu, Y-L., Arrieta, O., Calella, A.M., Peltz, G., Polli, A., Thurm, H., Bauer, T.M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1302P Lorlatinib in patients with ALK+ NSCLC treated beyond initial disease progression
Ou, S.I., Solomon, B., Shaw, A., Gadgeel, S.M., Besse, B., Soo, R.A., Abbattista, A., Thurm, H., Toffalorio, F., Wiltshire, R.J., Bearz, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Intracranial and extracranial efficacy of lorlatinib in the post second-generation ALK tyrosine kinase inhibitor (TKI) setting
Camidge, D.R., Solomon, B.J., Felip, E., Besse, B., Bearz, A., Peters, S., Toffalorio, F., Abbattista, A., Thurm, H., Peltz, G., Wiltshire, R., Shaw, A.T.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1487PDIntracranial and extracranial efficacy of lorlatinib in the post second-generation ALK tyrosine kinase inhibitor (TKI) setting
Camidge, D R, Solomon, B J, Felip, E, Besse, B, Bearz, A, Peters, S, Toffalorio, F, Abbattista, A, Thurm, H, Peltz, G, Wiltshire, R, Shaw, A T
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1487PD - Intracranial and extracranial efficacy of lorlatinib in the post second-generation ALK tyrosine kinase inhibitor (TKI) setting
Camidge, D.R., Solomon, B.J., Felip, E., Besse, B., Bearz, A., Peters, S., Toffalorio, F., Abbattista, A., Thurm, H., Peltz, G., Wiltshire, R., Shaw, A.T.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA2 Lorlatinib vs crizotinib in the first-line treatment of patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC): Results of the phase III CROWN study
Solomon, B., Bauer, T.M., De Marinis, F., Felip, E., Goto, Y., Liu, G., Mazieres, J., Kim, D-W., Mok, T., Polli, A., Thurm, H., Calella, A.M., Peltz, G., Shaw, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
OA02.03 Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6
Ou, S., Shaw, A., Riely, G., Chiari, R., Bauman, J., Clancy, J., Thurm, H., Peltz, G., Abbattista, A., Solomon, B.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
MA08.05 Brain Penetration of Lorlatinib and Cumulative Incidence Rates for CNS and Non CNS Progression from a Phase 1/2 Study
Bauer, T., Shaw, A., Johnson, M., Navarro, A., Gainor, J., Thurm, H., Pithavala, Y., Abbattista, A., Felip, E.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
MA11.08 Patient-Reported Outcomes from the Randomized Phase 3 CROWN Study of First-Line Lorlatinib versus Crizotinib in ALK+ NSCLC
Mazieres, J., Iadeluca, L., Shaw, A., Solomon, B., Bauer, T., De Marinis, F., Felip, E., Goto, Y., Kim, D., Mok, T., Reisman, A., Thurm, H., Polli, A., Liu, G.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
Cohen, E.E., Ferris, R.L., Psyrri, A., Haddad, R., Tahara, M., Bourhis, J., Harrington, K.J., Chang, P.M-H., Lin, J-C., Razaq, M., Teixeira, M.M., Lovey, J., Chamois, J., Rueda Dominguez, A., Hu, C., Dvorkin, M., De Beukelaer, S., Pavlov, D., Thurm, H., Lee, N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
P45.08 Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
Lu, S., Zhou, Q., Liu, X., Du, Y., Fan, Y., Cheng, Y., Fang, J., Lu, Y., Huang, C., Zhou, J., Song, Y., Wang, K., Pan, H., Yang, N., Li, J., Chen, G., Chang, J., Cui, J., Liu, Z., Bai, C., Zhang, H., Thurm, H., Peltz, G., Li, H., Zhao, H., Wu, Y.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
1380PDEfficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations
Solomon, B J, Martini, J-F, Ou, S-H I, Chiari, R, Soo, R A, Bearz, A, Li, S, Thurm, H, Lin, C-C, Riely, G J, Bauer, T M, Shaw, A T
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1542P - Safety of lorlatinib in subgroups of patients from a phase I/II trial
Felip, E., Solomon, B.J., Besse, B., Bauer, T.M., Soo, R.A., Camidge, D.R., Chiari, R., Bearz, A., Lin, C.-C., Gadgeel, S.M., Tan, E.-H., Seto, T., Oxnard, G.R., Peltz, G., Abbattista, A., Thurm, H., Toffalorio, F., Ou, S-H I, Shaw, A.T.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1542PSafety of lorlatinib in subgroups of patients from a phase I/II trial
Felip, E, Solomon, B J, Besse, B, Bauer, T M, Soo, R A, Camidge, D R, Chiari, R, Bearz, A, Lin, C-C, Gadgeel, S M, Tan, E-H, Seto, T, Oxnard, G R, Peltz, G, Abbattista, A, Thurm, H, Toffalorio, F, Ou, S-H I, Shaw, A T
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article